HLTRF (HLS Therapeutics) Dividend Yield % : 0.00% (As of Dec. 13, 2024)

View and export this data going back to 2010. Start your Free Trial

What is HLS Therapeutics Dividend Yield %?

As of today (2024-12-13), the Trailing Annual Dividend Yield of HLS Therapeutics is 0.00%.

The historical rank and industry rank for HLS Therapeutics's Dividend Yield % or its related term are showing as below:

During the past 13 years, the highest Dividend Yield of HLS Therapeutics was 11.76%. The lowest was 0.32%. And the median was 1.35%.

HLTRF's Dividend Yield % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 1.845
* Ranked among companies with meaningful Dividend Yield % only.

HLS Therapeutics's Dividend Payout Ratio for the three months ended in Sep. 2024 was 0.00.

During the past 13 years, the highest Dividend Payout Ratio of HLS Therapeutics was 0.25. The lowest was 0.25. And the median was 0.25.

As of today (2024-12-13), the Forward Dividend Yield % of HLS Therapeutics is 0.00%.

HLS Therapeutics's Dividends per Share for the three months ended in Sep. 2024 was $0.00.

During the past 12 months, HLS Therapeutics's average Dividends Per Share Growth Rate was -100.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was -19.50% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 10.60% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of HLS Therapeutics was 59.00% per year. The lowest was -19.50% per year. And the median was 22.80% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

HLS Therapeutics Dividend Yield % Historical Data

The historical data trend for HLS Therapeutics's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLS Therapeutics Dividend Yield % Chart

HLS Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dividend Yield %

Get a 7-Day Free Trial

0.79

1.08

1.38

2.10

1.93

HLS Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Dividend Yield %	Get a 7-Day Free Trial															2.89	1.93	1.21	-	-

Competitive Comparison of HLS Therapeutics's Dividend Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, HLS Therapeutics's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HLS Therapeutics's Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, HLS Therapeutics's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where HLS Therapeutics's Dividend Yield % falls into.

HLS Therapeutics Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

HLS Therapeutics (OTCPK:HLTRF) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

HLS Therapeutics Dividend Yield % Related Terms

Thank you for viewing the detailed overview of HLS Therapeutics's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

HLS Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HLS Therapeutics Inc (OTCPK:HLTRF) » Definitions » Dividend Yield %

Comparable Companies

Traded in Other Exchanges

HLS:Canada

Address

10 Carlson Court, Suite 701, Etobicoke, ON, CAN, M9W 6L2

Website

https://www.hlstherapeutics.com

HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company products include Clozaril, Vascepa, CSAN Pronto, and others. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, and the United States, and the Rest of the world.